• Certified Lab Equipment & Reagents
  • Fast Dispatch on In-Stock Items
  • Expert Scientific Support

Product details

BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL

Catalog number BNUB0886-500

Price for BNUB0886-500

Sign In for Pricing

Size / count 1x 500 µL

About this product

Bromodeoxyuridine (BrdU) is a synthetic nucleoside thymidine analog. It is commonly used to detect proliferation in cells. In cells cultured in the presence of BrdU, BrdU will incorporate into newly synthesized DNA during S-phase. Antibodies specific for BrdU can then be used to detect replicated DNA. This antibody is available purified, with BSA (0.2 mg/mL) or purified, BSA-free (1 mg/mL) .

Specifications

Catalog number
BNUB0886-500
Size / count
1x 500 µL
Dry ice
No
Hazardous
No
Discontinued
No
CAS Number
9007-83-4
Synonyms
Bromodeoxyuridine; 5-bromo-2-deoxyuridine
UNSPSC
41116161
UNSPSC Description
Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name
Not Applicable
UniProt
Not Applicable
Swiss Prot
Not Applicable
Host
Mouse
Species Reactivity
Pan species
Reactivity
BrdU
Immunogen
Bromodeoxyuridine (BrdU) conjugated to hemocyanine (isolated from Helix pomatia)
Target Antigen
BrdU
Clonality
Monoclonal
Clone
85-2C8
Type
Primary
Source
Animal
Origin
Animal
Applications
IHC, FFPE (verified)
Field of Research
Cancer, Cell cycle
Positive Control
Cells grown in presence of BrdU or tissues from experimental animals injected with BrdU
Stability
2 years
Concentration
0.2 mg/mL
Buffer
PBS, 0.05% BSA, 0.05% azide
Molecular Weight
Depends on the target
Shipping Conditions
RT (ND)
Storage Conditions
Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life
Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment
IgG1
Species
Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification
PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate
Purified, with BSA

Frequently Asked Questions

What is the catalog number for BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL?

The catalog number for BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL is BNUB0886-500.

What sizes are available for BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL?

BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL is available in the following size(s): 1x 500 µL.

Is BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL in stock?

BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL?

BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL is manufactured by Biotium.

What is the estimated delivery time for BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL?

Estimated delivery time for BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL?

The safety data sheet for BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is BrdU (Bromodeoxyuridine) (85-2C8), 0.2mg/mL used for?

Bromodeoxyuridine (BrdU) is a synthetic nucleoside thymidine analog. It is commonly used to detect proliferation in cells. In cells cultured in the presence of BrdU, BrdU will incorporate into newly synthesized DNA during S-phase. Antibodies specific for BrdU can then be used to detect replicated DN

Can I request a Safety Data Sheet (SDS) for this product?

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Can this product be used for co-immunoprecipitation (Co-IP)?

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Is this kit compatible with automated liquid handling platforms?

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

You Might Also Like
CD81 / TAPA-1 (1.3.3.22), CF647 conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470391-100
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740977-500
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC940679-500
ACTH (Adrenocorticotrophic Hormone) (AH26), CF740 conjugate, 0.1mg/mL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740026-500
CD3e (B-B12), CF640R conjugate, 0.1mg/mL
CD3e (B-B12), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC401052-100
FOXP3 (3G3), CF488A conjugate, 0.1mg/mL
FOXP3 (3G3), CF488A conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC880645-100
CD1a (O10 + C1A/711), CF647 conjugate, 0.1mg/mL
CD1a (O10 + C1A/711), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470717-500
WT1 (Wilm's Tumor 1) (WT1/857), CF405S conjugate, 0.1mg/mL
WT1 (Wilm's Tumor 1) (WT1/857), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040857-100